An Analytical Comparison of Dako 28-8 PharmDx Assay and an E1L3N Laboratory-Developed Test in the Immunohistochemical Detection of Programmed Death-Ligand 1
Crossref DOI link: https://doi.org/10.1007/s40291-016-0237-9
Published Online: 2016-09-26
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cogswell, John
Inzunza, H. David
Wu, Qiuyan
Feder, John N.
Mintier, Gabe
Novotny, James
Cardona, Diana M.
Funding for this research was provided by:
Bristol-Myers Squibb
License valid from 2016-09-26